We are live on ! Find out more
PTCT icon

PTC Therapeutics
PTCT

84 hedge funds and large institutions have $601M invested in PTC Therapeutics in 2014 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 36 increasing their positions, 12 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

238% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 8

200% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 12

29% more funds holding

Funds holding: 65 → 84 (+19)

0% more capital invested

Capital invested by funds: $600M → $601M (+$1.09M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
84
Holders Change
+19
Holders Change %
+29.23%
% of All Funds
2.41%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
27
Increased
36
Reduced
12
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SAM
Sectoral Asset Management
Quebec, Canada
+$12.9M
2
Millennium Management
Millennium Management
New York
+$9.57M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$9.13M
4
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$5.1M
5
BFA
BlackRock Fund Advisors
California
+$4.9M

Top Sellers

1
RCM
RA Capital Management
Massachusetts
-$25.7M
2
Jennison Associates
Jennison Associates
New York
-$22.5M
3
O
OrbiMed
New York
-$14M
4
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
-$12.4M
5
CAM
Cormorant Asset Management
Massachusetts
-$8.56M
Name Holding Trade Value Shares
Change 		Change in
Stake
GH
51
GAM Holding
Switzerland
$528K – – –
Swiss National Bank
52
Swiss National Bank
Switzerland
$518K – – –
RhumbLine Advisers
53
RhumbLine Advisers
Massachusetts
$500K +$409K +19,113 New
Manulife (Manufacturers Life Insurance)
54
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$487K +$50.2K +2,346 +14%
Jane Street
55
Jane Street
New York
$469K +$384K +17,947 New
MLICM
56
Metropolitan Life Insurance Company (MetLife)
New York
$458K +$139K +6,502 +59%
Royal Bank of Canada
57
Royal Bank of Canada
Ontario, Canada
$455K +$179K +8,385 +93%
NFA
58
Nationwide Fund Advisors
Ohio
$445K +$178K +8,307 +95%
Morgan Stanley
59
Morgan Stanley
New York
$430K +$80.5K +3,763 +30%
DC
60
Davenport & Co
Virginia
$392K +$321K +15,000 New
AIG
61
American International Group
New York
$380K +$171K +7,991 +122%
State Board of Administration of Florida Retirement System
62
State Board of Administration of Florida Retirement System
Florida
$369K +$302K +14,100 New
BACM
63
Blue Arrow Capital Management
New York
$353K -$53.5K -2,500 -16%
VOYA Investment Management
64
VOYA Investment Management
Georgia
$339K +$278K +12,970 New
N
65
Nuveen
North Carolina
$317K +$187K +8,758 New
Susquehanna International Group
66
Susquehanna International Group
Pennsylvania
$279K +$19.5K +909 +9%
Bank of Montreal
67
Bank of Montreal
Ontario, Canada
$269K +$220K +10,290 New
BOTOTLSJU
68
Board of Trustees of The Leland Stanford Junior University
California
$269K +$220K +10,295 New
Bank of America
69
Bank of America
North Carolina
$259K +$212K +9,905 +45,023%
PNC Financial Services Group
70
PNC Financial Services Group
Pennsylvania
$202K +$53.9K +2,520 +48%
Citigroup
71
Citigroup
New York
$184K -$30.2K -1,410 -17%
Barclays
72
Barclays
United Kingdom
$167K +$44.5K +2,077 +48%
Wells Fargo
73
Wells Fargo
California
$92K +$6.79K +317 +10%
EWM
74
Evercore Wealth Management
New York
$78K – – –
VFA
75
Virtus Fund Advisers
Connecticut
$50K +$40.5K +1,894 New
1 2
3
4

PTCT Hedge Fund Activity: Q2 2014 in Review

84 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in PTC Therapeutics (PTCT) for Q2 2014, worth a combined $601M — up 0.18% from $600M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new PTCT positions and 8 closed out — a net gain of 19 holders — while 36 added to existing stakes and 12 trimmed.

The largest buyer was Sectoral Asset Management, adding an estimated $12.9M. The largest seller was RA Capital Management, exiting entirely with an estimated $25.7M sold.

  • 84 institutional investors held PTC Therapeutics (PTCT) as of Q2 2014, up from 65 in Q1 2014.
  • Funds reported $601M of PTC Therapeutics stock for Q2 2014, up 0.18% quarter-over-quarter.
  • 27 funds opened new PTC Therapeutics positions in Q2 2014 and 8 closed out, a net change of +19 holders.
  • The largest PTC Therapeutics buyer in Q2 2014 was Sectoral Asset Management, an estimated $12.9M added.
  • The largest PTC Therapeutics seller in Q2 2014 was RA Capital Management, an estimated $25.7M sold.

Based on aggregated 13F filings for Q2 2014.